Literature DB >> 11446169

Control and stability of drug release from diffusion pellets coated with the aqueous quaternary polymethacrylate dispersion Eudragit RS 30 D.

B C Lippold1, R Monells Pagés.   

Abstract

The addition within compatibility limits of the pore formers hydroxypropyl methylcellulose (HPMC) and hydroxy ethylcellulose (HEC) to coatings of the quaternary polymethacrylate dispersion Eudragit RS 30 D enables drug release to be controlled without problems. 20 and 15%, respectively, of these pore formers are suitable for release within 8 h of theophylline from pellets with a coating thickness of about 30 microns. A 10% addition of plasticizer, water soluble triethyl citrate (TEC) or water insoluble dibutyl phthalate (DBP), lowers the minimum film forming temperature (MFT) from 48 to 17 and 26 degrees C, respectively. The MFT is scarcely influenced by the pore formers. However, the plasticizers may modify the effect of the pore formers: HPMC is more effective in the presence of DBP. In spite of the preparation of the coatings at a bed temperature about 20 degrees C above MFT, the release from the diffusion pellets is not stable during storage. Only curing in an oven or in the fluidized bed up to a certain limiting release rate at 80 degrees C for 1 h results in stable products. Increased relative humidity allows reduction of the curing temperature. The water soluble additives polyoxy ethylene (PEG) and polyvinyl pyrrolidone (PVP) and insoluble additives are ineffective as pore formers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11446169

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  5 in total

1.  Development and evaluation of a novel modified-release pellet-based tablet system for the delivery of loratadine and pseudoephedrine hydrochloride as model drugs.

Authors:  Farrukh Zeeshan; Nadeem Irfan Bukhari
Journal:  AAPS PharmSciTech       Date:  2010-05-22       Impact factor: 3.246

2.  Dry powder coating of pellets with micronized Eudragit RS for extended drug release.

Authors:  Nantharat Pearnchob; Roland Bodmeier
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

3.  Effect of Eudragit RS 30D and talc powder on verapamil hydrochloride release from beads coated with drug layered matrices.

Authors:  Yasser El-Malah; Sami Nazzal
Journal:  AAPS PharmSciTech       Date:  2008-01-09       Impact factor: 3.246

4.  Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism.

Authors:  Robert Wulff; Claudia S Leopold
Journal:  AAPS PharmSciTech       Date:  2015-08-12       Impact factor: 3.246

5.  Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions.

Authors:  Wenji Zhang; Xuedong Li; Tiantian Ye; Fen Chen; Shihui Yu; Jianting Chen; Xinggang Yang; Na Yang; Jinsong Zhang; Jinlu Liu; Weisan Pan; Jun Kong
Journal:  Int J Nanomedicine       Date:  2014-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.